CG Oncology

CG Oncology is focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2024
Stage of Initial Investment
Series E
Initial Investment Year
2022